‹ All Posts
Prachi Mehta

16th Feb · SEBI-Registered Analyst

Stocks in news today

NATCOPHARM
has received approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March 2026. Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
ASHOKA
has received Letter of Award (LoA) from Ministry of Public Works, Liberia (the Authority) for the Project viz. ‘Upgrading of the Road from Nrowkia (Sasstown Jn) to Barclayville and Nrowkia (Sasstown Jn) to Sasstown and Part of Nrowkia (Sasstown Jn) to Nipleppo road Project in Republic of Liberia’. The accepted Bid Cost of the project is $45,276,621.07. The said project is expected to be completed in 24 months.
ZYDUSLIFE
has received final approval from the United States Food and Drug Administration (USFDA) for Ammonium Lactate Cream, 12% (USRLD: Lac-Hydrin Cream, 12%). Ammonium lactate cream, 12% is a topical prescription medication indicated for the treatment of dry, scaly skin (xerosis) and an inherited dry skin condition called ichthyosis vulgaris. It is used to moisturise the skin by increasing hydration and, as an alpha-hydroxy acid, helps relieve itching, soften skin, and decrease skin scaling. Royal Orchid & Regenta Hotels, India's fastest-growing hospitality chain by Royal Orchid Hotels (ROHL), has signed a management contract for Regenta Z-Vrindavan, Mathura. This new property marks a significant addition to the group's portfolio, catering to the rising demand for branded hospitality in one of India's most sacred destinations. International Conveyors has acquired the entire share capital of International Conveyors Australia Pty (ICL Australia), erstwhile step-down subsidiary of the Company from Conveyor Holding (CHPL) (subsidiary of the Company). Pursuant to the said acquisition, ICL Australia has become direct subsidiary of the Company.

#TechnicalViews#FundamentalViews#StockInNews#WatchOutFor#EquityResearch
770 likes·71 comments